目的 觀察注射用纖溶酶與阿司匹林（乙酰水楊酸）聯(lián)合治療腦梗死的臨床效果。方法 對福建晉江市醫(yī)院2011年1月-2012年12月收治的160例腦梗死患者（均發(fā)病后6 h以上入院，不適合靜脈溶栓）隨機分為2組。治療組靜脈滴注纖溶酶200 U加100 mg阿司匹林口服1 次/d，對照組僅口服相同劑量的阿司匹林，兩組均常規(guī)口服20 mg阿托伐他汀1 次/d，共治療2周。比較治療前后血液流變學指標變化，以及治療1個月、6個月后的預后。結(jié)果 治療組肢體癱瘓較對照組明顯好轉(zhuǎn)，效果明顯優(yōu)于對照組，無明顯病情加重病例。結(jié)論 注射用纖溶酶與阿司匹林聯(lián)合治療腦梗死，安全有效，值得推廣應用。

Objective To observe the effect of injectable fibrinolysin and Aspirin (acetylsalicylic acid) in treatment of cerebral infarction. Methods Patients with cerebral infarction (160 cases) presenting more than 6 h after symptom onset from January 2011 to December 2012 admitted to Jinjiang Municipal Hospital were randomly divided into treatment group (injectable fibrinolysin iv ggt 200 U and acetylsalicylic acid po 100 mg) and control group (Aspirin po 100 mg). The patients in both groups were treated with atorvastatin (20 mg/d ) for 2 weeks. Results The patients in the treating group had better paralysis recovery than those in the control group. Conclusion The therapy of injectable fibrinolysin and Aspirin is effective and safe.